Integrated BioPharma, Inc. (INBP) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Integrated BioPharma, Inc. (INBP) Consumer Business Overview

Integrated BioPharma, Inc. (INBP) operates in the consumer defensive sector, specializing in the creation, distribution, promotion, and sale of vitamins, nutritional supplements, and herbal items across the U.S., Luxembourg, and Canada. The company employs a dual strategy, encompassing contract manufacturing for diverse clients and distributing proprietary and private-label wellness products through various retail channels and online.

What Is the Investment Thesis for INBP?

Integrated BioPharma, Inc. (INBP) presents a unique operational profile within the consumer defensive sector, characterized by its dual business model encompassing both contract manufacturing and the distribution of proprietary and private-label nutraceutical products. A key value driver is the company's established presence in the growing wellness market across the U.S., Luxembourg, and Canada, leveraging its 1980 founding date for industry experience. The Contract Manufacturing segment provides a foundational revenue stream by serving diverse clients, while the Other Nutraceutical Businesses segment offers growth potential through proprietary brands like Peaceful Sleep and Wheatgrass, alongside expanding private-label and e-commerce initiatives. However, the company's financial metrics indicate areas for close investor scrutiny, including a negative profit margin of -3.4% and a low gross margin of 4.6%. With a market capitalization of $5.59M, INBP operates as a micro-cap entity. Growth catalysts include the increasing global demand for health supplements, potential expansion of its client base in contract manufacturing, and enhanced market penetration for its owned brands. The company's beta of 0.36 suggests lower volatility relative to the broader market. Risks are primarily associated with its profitability challenges, intense competition in the nutraceutical space, and the inherent characteristics of its OTC Other listing, which implies less stringent disclosure and potentially lower liquidity.

Based on FMP financials and quantitative analysis

INBP Key Highlights

Market capitalization of $5.59M, positioning INBP as a micro-cap company within the consumer defensive sector.

• A negative profit margin of -3.4% indicates current unprofitability, requiring careful financial monitoring.
• Gross margin stands at 4.6%, reflecting a relatively low profitability on sales before operating expenses.
• A Beta of 0.36 suggests lower stock price volatility compared to the overall market, potentially appealing to risk-averse investors.
• Operates with 147 employees, supporting its dual segments of contract manufacturing and nutraceutical product distribution.

Who Are INBP's Competitors?

INBP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are INBP's Key Strengths?

Dual business model provides diversified revenue streams from contract manufacturing and branded product sales.

• Established proprietary brands such as Peaceful Sleep and Wheatgrass with market presence.
• Integrated services including manufacturing, warehousing, and order fulfillment.
• Long operating history since 1980, indicating experience and stability in the industry.
• Geographic presence in the U.S., Luxembourg, and Canada.

What Are INBP's Weaknesses?

Negative profit margin of -3.4% indicates current unprofitability.

• Low gross margin of 4.6% suggests limited pricing power or high production costs.
• Small market capitalization of $5.59M, potentially limiting access to capital.
• OTC Other listing implies less stringent disclosure requirements and potentially lower liquidity.
• Unknown disclosure status, making comprehensive investor analysis challenging.

What Could Drive INBP Stock Higher?

INBP catalyst: Growing consumer demand for health and wellness products, including vitamins, nutritional supplements, and herbal items, particularly in its operating markets of the U.S., Luxembourg, and Canada.

• Expansion of the private-label market, which could drive increased demand for INBP's private-label vitamin and supplement products offered directly online and through retail channels.
• Potential for new product development or line extensions under its proprietary brands, such as Peaceful Sleep and Wheatgrass, to capture evolving consumer preferences and market trends.
• Strategic partnerships or increased client acquisition within its Contract Manufacturing division, leveraging its formulation and production capabilities for dietary supplements.
• Continued growth in e-commerce for health products, enhancing the reach and sales potential of INBP's online offerings.

What Are the Key Risks for INBP?

Financial-distress signal — its Altman Z-Score of 0.92 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-8.3%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Sustained negative profit margin of -3.4% and a low gross margin of 4.6% indicate persistent profitability challenges.
• Intense competition within the fragmented nutraceutical and dietary supplement market from numerous established and emerging brands.
• Regulatory changes or increased scrutiny in the dietary supplement industry across the U.S., Luxembourg, and Canada, which could impact product formulation, marketing, or distribution.
• Inherent risks associated with its OTC Other listing, including potentially lower liquidity, wider bid-ask spreads, and limited public disclosure, making investment more speculative.
• Fluctuations in raw material costs or disruptions in the supply chain for natural botanicals and other ingredients, impacting production costs and product availability.

What Are the Growth Opportunities for INBP?

• **Expansion in Contract Manufacturing Services:** The global market for contract manufacturing in the nutraceutical sector is experiencing steady growth, driven by increasing demand for dietary supplements and functional foods, coupled with a trend among brand owners to outsource production to specialized facilities. INBP's Contract Manufacturing division, which formulates vitamins and dietary supplements for distributors, multi-level marketing firms, and healthcare practitioners, is well-positioned to capitalize on this trend. By expanding its client base, enhancing its manufacturing capabilities, and potentially diversifying its product formulation expertise, INBP could secure larger contracts and increase its market share. This growth driver offers a stable, B2B revenue stream with potential for long-term partnerships, leveraging its established operational history since 1980.
• **Leveraging Proprietary Brands and E-commerce:** INBP's proprietary brands, including "Peaceful Sleep" and "Wheatgrass," represent a significant growth opportunity. As consumer interest in specific health solutions like sleep aids and natural wellness products continues to rise, investing in brand building, targeted marketing, and product innovation for these labels can drive increased sales and market penetration. Furthermore, the company's existing direct-to-consumer online sales channel for private-label vitamin and supplement products can be expanded. The e-commerce market for health and wellness products is projected for substantial growth, offering a cost-effective way to reach a broader customer base and build brand loyalty without extensive physical retail infrastructure.
• **Increased Demand for Private-Label Nutraceuticals:** The market for private-label products across various retail channels, including supermarkets and specialty stores, continues to expand as retailers seek to offer more affordable alternatives and build their own brand equity. INBP's capability to offer private-label vitamin and supplement products directly online, alongside its distribution to a wide range of retail outlets, positions it to capture this growing demand. By enhancing its private-label offerings, improving supply chain efficiencies, and forging stronger partnerships with retailers, INBP can tap into this significant market segment, which often provides higher margins and greater control over product development and pricing.
• **Geographic Market Penetration:** While INBP currently operates in the United States, Luxembourg, and Canada, there is potential for deeper penetration within these existing markets and strategic expansion into new international territories. The global nutraceutical market is diverse, with varying consumer preferences and regulatory environments. By conducting targeted market research, adapting product formulations to local tastes and regulations, and establishing new distribution partnerships, INBP could unlock new revenue streams. Focusing on regions with high growth rates for health supplements or underserved markets could provide substantial long-term growth, leveraging its existing international experience in Luxembourg and Canada.
• **Diversification and Supply Chain Integration:** INBP's role in supplying high-quality natural botanicals, encompassing multi-minerals and various raw materials, represents an opportunity for further diversification and enhanced supply chain integration. By expanding its portfolio of raw materials and potentially offering these to a broader external client base beyond its internal needs, INBP could establish itself as a key supplier in the nutraceutical ingredient market. This vertical integration not only provides an additional revenue stream but also strengthens the company's control over the quality and cost of its own product inputs, offering a competitive advantage in terms of product integrity and manufacturing efficiency.

What Are INBP's Competitive Advantages?

• Established dual business model combining B2B contract manufacturing with B2C branded product distribution.
• Proprietary brands like Peaceful Sleep and Wheatgrass, which have market presence and consumer recognition.
• Integrated supply chain capabilities, from raw material sourcing to manufacturing, warehousing, and fulfillment.
• Long operational history since 1980, indicating deep industry experience and established relationships.
• Geographic reach across the U.S., Luxembourg, and Canada, diversifying market exposure.

What Does INBP Do?

Integrated BioPharma, Inc. (INBP), established in 1980 and formerly known as Integrated Health Technologies, Inc., has evolved into a key player in the nutritional supplement and herbal products market. Headquartered in Hillside, New Jersey, the company's core business revolves around the creation, distribution, promotion, and sale of a diverse range of vitamins, nutritional supplements, and herbal items. Its operational footprint extends across significant markets, including the United States, Luxembourg, and Canada, reflecting a strategic international presence within the consumer defensive sector. INBP's business model is distinctly segmented into two primary divisions: Contract Manufacturing and Other Nutraceutical Businesses. The Contract Manufacturing division serves as a vital partner for a varied client base, undertaking the formulation and production of vitamins and dietary supplements. This segment caters to distributors, multi-level marketing firms, and professional healthcare practitioners, providing tailored manufacturing solutions that leverage the company's expertise in nutraceutical development. This B2B approach offers a steady revenue stream and leverages specialized production capabilities. The Other Nutraceutical Businesses segment focuses on the direct distribution of wellness-oriented nutritional products to a broad spectrum of retail outlets. These include general retailers, major supermarkets, pharmacies, and specialty vitamin stores, ensuring wide market accessibility for its offerings. This segment is notable for featuring INBP's proprietary brands, such as "Peaceful Sleep" and "Wheatgrass," alongside other owned nutraceutical labels, which are strategically positioned to capture specific consumer health trends. Furthermore, this division extends its reach through the direct online sale of private-label vitamin and supplement products, tapping into the growing e-commerce market for health goods. Complementing its product distribution, INBP also provides essential warehousing and order fulfillment services, enhancing its logistical capabilities. The company further strengthens its supply chain by supplying high-quality natural botanicals, including multi-minerals and various raw materials, to both internal operations and potentially external clients, underscoring its integrated approach to the nutraceutical value chain.

What Products and Services Does INBP Offer?

• Formulate vitamins and dietary supplements for various clients.
• Manufacture nutraceutical products under contract for distributors and healthcare practitioners.
• Distribute wellness-focused nutritional products to a wide range of retail outlets.
• Market and sell proprietary brands such as Peaceful Sleep and Wheatgrass.
• Offer private-label vitamin and supplement products directly through online channels.
• Provide warehousing and order fulfillment services for its products and potentially for clients.
• Supply high-quality natural botanicals, including multi-minerals and other raw materials.
• Operate in the United States, Luxembourg, and Canada.

How Does INBP Make Money?

• Generates revenue from contract manufacturing services for vitamins and dietary supplements.
• Earns income from the sale of its proprietary branded nutraceutical products to retailers and consumers.
• Derives revenue from the sale of private-label vitamin and supplement products, primarily online.
• Receives fees for warehousing and order fulfillment services provided.
• Generates sales from supplying natural botanicals, multi-minerals, and other raw materials.

What Industry Does INBP Operate In?

Integrated BioPharma, Inc. (INBP) operates within the Packaged Foods industry, specifically focusing on the dynamic and expanding nutraceuticals and dietary supplements segment of the broader Consumer Defensive sector. This industry is currently experiencing robust growth, driven by increasing consumer awareness of preventative health, an aging global population, and a rising preference for natural and wellness-focused products. Market trends indicate a sustained demand for vitamins, herbal remedies, and specialized nutritional supplements, with significant opportunities in both branded and private-label offerings. INBP's positioning is somewhat unique due to its dual operational segments. The Contract Manufacturing division places it within the B2B supply chain for nutraceuticals, competing with other specialized manufacturers who offer formulation and production services. This segment benefits from the outsourcing trends within the industry, as brands seek efficient and compliant manufacturing partners. Concurrently, its Other Nutraceutical Businesses segment, with proprietary brands like Peaceful Sleep and Wheatgrass, and its private-label online sales, positions INBP directly in the B2C retail landscape. Here, it competes with a vast array of established supplement brands, pharmaceutical companies with wellness divisions, and numerous smaller, agile direct-to-consumer brands. The competitive landscape is fragmented, characterized by continuous product innovation and evolving consumer preferences, necessitating strong brand loyalty and efficient distribution networks to gain market share.

Who Are INBP's Key Customers?

• Distributors of nutritional supplements and health products.
• Multi-level marketing firms in the wellness industry.
• Professional healthcare practitioners seeking custom formulations.
• General retailers, supermarkets, pharmacies, and specialty vitamin stores.
• Direct-to-consumer online customers purchasing private-label and proprietary products.

How Integrated BioPharma, Inc. Is Valued

Integrated BioPharma, Inc. carries a market capitalization of $5.59M, placing it in the micro-cap category. Relative to its peer group, INBP's quantitative score of 40/100 is below the peer average of 61/100.

Company Profile

Integrated BioPharma, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Hillside, US. The company is led by CEO Riva Sheppard. INBP has traded publicly since 1996.

Return on equity for Integrated BioPharma, Inc. stands at -8.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -6.2%, showing how much profit it generates from its asset base. Its free cash flow yield is 50.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.25 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -29.6%, the inverse of the P/E and a quick read on earnings relative to price.

Integrated BioPharma, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.92 places it in the distress zone, a signal of elevated financial risk.

INBP Financials

INBP Latest News

No recent news available for INBP.

INBP Analyst Consensus

INBP MoonshotScore

Integrated BioPharma, Inc. Consumer Defensive Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources